Clinical trial
Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension:a Single-center, Prospective, Randomized Controlled Study
NCT07064434 is registered in ClinicalTrials.gov with General Hospital of Ningxia Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension:a Single-center, Prospective, Randomized Controlled Study
- Lead sponsor
- General Hospital of Ningxia Medical University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 1, 2024
- Completion date
- October 30, 2025
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.